Prevention of endotoxin shock through targeting leukocyte adhesion molecules.
Higashi
H
H
Department of Pharmacology, School of Medicine, Kanazawa University, Japan.
Mukaida
N
N
Harada
A
A
Watanabe
S
S
Ikeda
N
N
Suzuki
Y
Y
Matsushima
K
K
D000818:Animals; D018821:CD18 Antigens / Q000502:physiology; D015815:Cell Adhesion Molecules / Q000494:pharmacology*; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D019041:L-Selectin / Q000502:physiology; D008070:Lipopolysaccharides / Q000494:pharmacology; D051379:Mice; D019007:P-Selectin / Q000502:physiology; D011817:Rabbits; D012772:Shock, Septic / Q000517:prevention & control*; D013433:Sulfoglycosphingolipids / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D018821:CD18 Antigens; D015815:Cell Adhesion Molecules; D016207:Cytokines; D008070:Lipopolysaccharides; D019007:P-Selectin; D013433:Sulfoglycosphingolipids; D014409:Tumor Necrosis Factor-alpha; D019041:L-Selectin